|
ACC abstracts are out
|
5
|
Resverlogix Corp.
|
Mar 06, 2017 10:57PM
|
|
Zenith Abstract at AACR 2017 Meeting April 1-5
|
4
|
Zenith Epigenetics
|
Mar 07, 2017 03:41PM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
6
|
Zenith Epigenetics
|
Mar 07, 2017 11:12PM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
4
|
Zenith Epigenetics
|
Mar 08, 2017 08:36AM
|
|
pmrider's "My Take" thread from Stockhouse
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 08, 2017 01:44PM
|
|
Slide Deck from Cowen Health Care Conference 3/8/17
|
6
|
Resverlogix Corp.
|
Mar 08, 2017 03:41PM
|
|
Re: Cheeseburgers and Pork Ribs
|
2
|
Resverlogix Corp.
|
Mar 09, 2017 05:09PM
|
|
Re: 3 Weeks To The 31st
|
5
|
Zenith Epigenetics
|
Mar 10, 2017 11:22AM
|
|
Re: 3rd Quarter Financial Statements
|
2
|
Resverlogix Corp.
|
Mar 14, 2017 01:15PM
|
|
March Madness
|
5
|
Resverlogix Corp.
|
Mar 14, 2017 03:35PM
|
|
Re: March Madness
|
3
|
Resverlogix Corp.
|
Mar 14, 2017 04:09PM
|
|
Re: Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
|
3
|
Resverlogix Corp.
|
Mar 15, 2017 09:16AM
|
|
Re: 3 Weeks To The 31st
|
3
|
Zenith Epigenetics
|
Mar 15, 2017 09:21AM
|
|
Re: "ONE of the KEY patents !"
|
1
|
Resverlogix Corp.
|
Mar 15, 2017 09:42AM
|
|
Re: 3rd Quarter Financial Statements
|
2
|
Resverlogix Corp.
|
Mar 15, 2017 10:27PM
|
|
Resverlogix Announces Third Positive Recommendation From DSMB For Phase 3 BETonMACE
|
1
|
Resverlogix Corp.
|
Mar 17, 2017 08:38AM
|
|
Re: Resverlogix Announces Third Positive Recommendation From DSMB For Phase 3 BETonMACE
|
2
|
Resverlogix Corp.
|
Mar 17, 2017 08:47AM
|
|
Re: Amgen's Acclaimed 20% MACE reduction referred to as "slashing heart attack rates"
|
1
|
Resverlogix Corp.
|
Mar 17, 2017 02:05PM
|
|
Re: Amgen's Acclaimed 20% MACE reduction referred to as "slashing heart attack rates"
|
5
|
Resverlogix Corp.
|
Mar 17, 2017 02:50PM
|
|
Re: Esperion
|
5
|
Resverlogix Corp.
|
Mar 20, 2017 11:50AM
|
